- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care Businesses
Indiana to receive nearly $793K in Amgen settlement
December 20, 2012
Associated PressAmgen Inc. has agreed to pay Indiana nearly $793,000 as part of a larger settlement to resolve allegations it paid kickbacks
to physicians who prescribed some of its drugs for unapproved uses.
MoreLilly OKs $1.5B share buyback, first quarter dividend
December 18, 2012
Associated PressIndianapolis-based drugmaker Eli Lilly and Co. said Monday that its board authorized a $1.5 billion share-repurchase program,
which the company expects to complete next year.
MoreHealth care pricing service comes to Indy
December 17, 2012
J.K. WallChicago-based OkCopay Inc. posts prices offered by Indianapolis health care providers, many of which have agreed to give cash-paying patients a price roughly equivalent to those charged to insured customers. The site also includes pricing information from health care providers that do not give cash-paying patients an additional break.
Lilly discontinues late-stage trial in rheumatoid arthritis
December 13, 2012
Bloomberg NewsEli Lilly and Co. said it discontinued a last-stage trial of experimental rheumatoid arthritis drug tabalumab for lack of
efficacy. Lilly is still evaluating the drug in the two other late-stage studies.
MoreLilly notifies Canada about NAFTA complaint on Strattera patent
December 6, 2012
Bloomberg NewsEli Lilly and Co. notified Canada it plans to file a trade complaint, claiming court decisions invalidating one of the company’s
patents breach international obligations.
MoreIllinois company to hire 50 in Indy for Medicaid drug contract
December 3, 2012
J.K. WallCatamaran Corp. will add 50 jobs in Indianapolis over the next year to help it provide pharmacy-benefit-management services
to the Indiana Medicaid program. The Illinois-based company will open an office downtown Tuesday to kick off its six-year,
$60 million contract with the state.
MoreLilly chief says China too slow in approving new drugs
November 28, 2012
Bloomberg NewsChina takes eight years longer on average to approve drugs than other major countries, and U.S. drugmakers are looking at
ways to help speed things up, Eli Lilly and Co. CEO John Lechleiter said.
MoreLilly donating $12.4 million to United Way
November 19, 2012
IBJ StaffEli Lilly and Co. said Monday it plans to give $12.4 million to the United Way, the largest single charitable donation in
the company’s history.
MoreIndy loses promising health startup
November 12, 2012
J.K. WallLabDoor, which soon will launch an iPhone app that assigns A-F grades to over-the-counter vitamins and medicines, moved last
month from Indianapolis to San Francisco, where it received $100,000 in startup financing.
MoreHoosier colleges discover patents aren't just for faculty anymore
November 10, 2012
Chris O'MalleyUniversities that once focused on faculty inventions now are encouraging students to pursue patents. Last year, 355 Purdue
University students filed a patent, a 62-percent jump from 218 student-filed patents the previous year.
MoreLilly to spend $140M on new insulin cartridge plant
November 1, 2012
J.K. WallAbout 100 workers will staff the new plant, which will be constructed by spring 2014 and ready for operations in 2015. But
only “some” of that number will be new hires.
MoreLilly plans expansion of local insulin plant
October 30, 2012
J.K. WallThe Indianapolis-based drugmaker plans to expand its local insulin plants to make insulin cartridges to meet what it describes
as growing demand in the United States.
MoreLilly's Cialis receives European approval for new use
October 30, 2012
Associated PressThe European Union has approved Eli Lilly and Co.'s erectile dysfunction drug Cialis to treat symptoms tied to an enlarged
prostate.
MoreColts QB Luck, Riley Hospital reach multiyear promotional deal
October 30, 2012
Anthony SchoettleIndianapolis Colts rookie quarterback Andrew Luck on Tuesday will announce his first local sponsorship deal, a four-year pact
with Riley Hospital for Children at Indiana University Health.
MoreZimmer trims full-year forecast after quarterly profit falls
October 25, 2012
J.K. WallThe Warsaw-based maker of orthopedic implants beat analysts’ estimates with its third-quarter earnings, but lowered
its full-year forecast.
MoreLilly CEO calls for life sciences research institute
October 23, 2012
J.K. WallEli Lilly CEO John Lechleiter on Tuesday called for creation of a "world-class" research institute in Indianapolis to bring
together scientists from universities and corporations to develop new medical therapies and companies.
MoreLilly says experimental diabetes drug outperformed rivals
October 22, 2012
J.K. WallEli Lilly and Co. said dulaglutide lowered blood sugar better than three existing diabetes drugs in three Phase 3 clinical
trials. Analysts expect the drug to hit the market in 2014 or 2015 and become a blockbuster.
MoreAlzheimer’s prevention seen promising as drug cures fail
October 19, 2012
Bloomberg NewsResearchers are set to test drugs by Eli Lilly and other companies that may prevent Alzheimer’s disease after efforts
to find a cure have been unsuccessful.
MoreLawsuit claims Aspen Dental clinics operating illegally
October 18, 2012
Associated PressA federal lawsuit filed in New York claims Aspen Dental Management and the private equity firm that controls it illegally
operate dental clinics across the country. The company operates 29 offices in Indiana.
MoreLilly stomach-cancer drug helps survival, study finds
October 15, 2012
Bloomberg NewsEli Lilly and Co. shares rose nearly 5 percent Monday morning after it said a study found that its experimental stomach-cancer
drug helped patients with advanced disease live longer.
MoreState drug fraud cases on the rise, study says
September 27, 2012
Associated PressFederal and state prosecutors have collected more than $30 billion from drug companies for alleged fraud and illegal marketing
over the last 20 years, according to a new report by consumer advocacy group Public Citizen.
MoreLilly competitor Novo investing $100M in China
September 24, 2012
Bloomberg NewsNovo Nordisk A/S, the world’s largest insulin maker, plans to spend $100 million on research in China. The move follows
a similar one by Indianapolis-based Eli Lilly, which opened a 150-person research center in Shanghai in May.
MoreTen drugmakers team up to improve testing process
September 19, 2012
Associated PressPharmaceutical industry heavyweights, including Eli Lilly and Co., are teaming up to improve the way experimental drugs are
tested so they can get approved, and reach patients, faster.
MoreFDA drug-review deal may unravel as fiscal cliff looms
September 10, 2012
Bloomberg NewsA $6.4 billion accord for U.S. drug and medical-device reviews is set to unravel just three months after taking effect as
lawmakers squabble over budget cutbacks.
MoreLilly’s Alimta fails to extend survival in lung cancer study
September 6, 2012
Bloomberg NewsEli Lilly and Co. said Thursday that its cancer drug Alimta didn’t extend overall survival when combined with Roche
Holding AG’s Avastin in patients with a form of lung tumor.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
It's also across the street from Fogo de Chao and Morton's....
Yep, the haters are trying to make good news bad. I guess it is hard to get people to believe the series is dying when they are gaining new sponsors.
David Copperfield! I remember watching his specials on TV when I was little.
Don't forget this is next to an MMA gym, a pawn shop, and some abandoned spaces.
Good project for Zionsville - A group who has owned the property for many years has waited and worked patiently to bring highest and best use development to a major corridor, and mix that in with the great downtown you have. Win Win. All the Best to Pittman Partners and Zionsville.